プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Anuj K.に依頼

France

Scientific Writer and Proof-reader with 10+ years of experience in research l PhD in Virology

プロフィール概要

-Research Scientist with PhD and Postdoc in Virology. -10+ years of experience in academic writing--- research articles, reviews, grants, fellowships, conference abstracts etc. EXPERTISE: RNA viruses, Antiviral therapeutics, Vaccines, Virus-Cell interactions ACCOMPLISHMENTS: • 2017 : International postdoctoral grant-fellowship by French Agency for Research on AIDS and Viral Hepatitis • 2015: Postdoc fellowship by Department of Biotechnology (DBT), Govt of India • 2014: Achievement Fellowship by Indian Institute of Science, Bangalore, India. • 2014: Science Scholar Award by Ranbaxy-Sun Pharmaceutical Industrial Ltd, India for PhD research • 2012: Best poster presentation award at 10th ICAV International Symposium on Virology • 2009: CSIR-PhD fellowship by Govt. of India.

専門分野

• ★ Virology
• ☆ Retrovirology
• ☆ Molecular Virology
• ☆ Molecular Biology
• ☆ Cell Culture
• ☆ Science Communication

サービス

• Writing
• Research
• Data & AI

Writing Technical Writing, Copywriting, Newswriting

Research Market Research, Gap Analysis, Systematic Literature Review

Data & AI Statistical Analysis

職務経験

Freelance Scientific Communicator

Freelance scientific communicator

9月 2020 - 現在

Researcher and Scientific Writer

INSERM -French National Institute of Health and Medical Research

6月 2017 - 8月 2021

Postdoctoral Researcher and Scientific Writer

National Centre for Biological Sciences

7月 2015 - 5月 2017

学歴

PhD in Virology

Indian Institute of Science, Bangalore, India

8月 2009 - 1月 2015

MSc Life Sciences (School of Life Sciences)

Jawaharlal Nehru University

2007 - 2009

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2018). Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

(2017). A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage . Antiviral research.

(2017). IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65 . Oncotarget.

(2017). Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies . The Journal of general virology.

(2015). Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy . Vaccine.

(2015). A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells . Nanoscale.

(2015). HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication . Journal of virology.

(2014). Small molecule inhibitors of HCV replication from pomegranate . Scientific reports.

(2014). Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator . The Journal of general virology.

(2014). Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus . Journal of virology.

(2013). Human La protein interaction with GCAC near the initiator AUG enhances hepatitis C Virus RNA replication by promoting linkage between 5' and 3' untranslated regions . Journal of virology.

(2013). Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system . PloS one.

(2013). A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus . Antiviral research.

(2012). Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy . Molecular therapy : the journal of the American Society of Gene Therapy.